Whoop, a Boston-based health wearable company, has made a significant shift in its focus from being a tool for serious athletes to a continuous health monitor that aims to save lives. This change in direction is crucial, as it has the potential to impact millions of people worldwide, especially in countries with limited access to healthcare. Whoop's wearable device, which measures sleep, recovery, heart rate variability, and biomarkers, has already gained popularity among athletes, with notable users including LeBron James and Cristiano Ronaldo. The company's subscription model has proven to be successful, with 83% of monthly active users opening the app daily.
Whoop's revenue grew by over 100% last year, and the company reached cash-flow positive. The device's partnership with Quest Diagnostics allows users to take blood tests and upload their biomarkers directly into the app, where a clinician reviews the results alongside their Whoop data. This feature, combined with the company's medically cleared features such as ECG monitoring and atrial fibrillation detection, positions Whoop as a leader in the health wearable market.
The company's decision to move beyond its roots and target a broader audience is a strategic one. Whoop's apparel line, launched in 2021, grew 70% last year, indicating that the company is successful in appealing to customers beyond its core athletic demographic.
Whoop's focus on becoming a life-saving device is a significant development in the health wearable market. As the company continues to innovate and expand its features, it will be interesting to see how it adapts to the changing needs of its users. Whoop's success in Nigeria and Africa will depend on its ability to make its device accessible and affordable to a wider audience. The company's partnership with Quest Diagnostics is a step in the right direction, but more needs to be done to make health wearables a mainstream phenomenon in Africa.
